Alahmadi, Amerh
Dmello, Anil
Article History
Received: 2 August 2022
Accepted: 26 October 2022
First Online: 14 November 2022
Declarations
:
: Research in our laboratory has received the following patent:U.S. Patent Application No: 15/495,410, allowed October 16, 2018.Title: Compositions and methods for the treatment of Phenylketonuria (PKU).The University of the Sciences has licensed the technology to Abri LLC and the corresponding author owns minority stake in the company.